CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....
Phase 1, Phase 2
Louisville, Kentucky, United States and 14 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Louisville, Kentucky, United States and 31 other locations
of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comp...
Phase 1
Louisville, Kentucky, United States and 6 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Louisville, Kentucky, United States and 143 other locations
ciloleucel, or lisocabtagene maraleucel) for diffuse large B-cell lymphoma that has come back (recurrent) or that does not respond to treatm...
Phase 2
Louisville, Kentucky, United States and 75 other locations
A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma...
Phase 2
Louisville, Kentucky, United States and 175 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Louisville, Kentucky, United States and 37 other locations
trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two phases. The primary object...
Phase 1, Phase 2
Louisville, Kentucky, United States and 20 other locations
and cyclophosphamide alone in a lymphodepletion regimen prior to ALLO-501A CAR T therapy in adults with relapsed or refractory large B-cell lymphoma...
Phase 2
Louisville, Kentucky, United States and 1 other location
of ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refra...
Phase 1, Phase 2
Louisville, Kentucky, United States and 22 other locations
Clinical trials
Research sites
Resources
Legal